DrugPatentWatch Database Preview
FUROSEMIDE Drug Profile
see a sample report or, see our see our flat-rate plans
Which patents cover Furosemide, and when can generic versions of Furosemide launch?
Furosemide is a drug marketed by Abraxis Pharm, Accord Hlthcare, Amneal Pharms Co, Astrazeneca, Baxter Hlthcare Corp, Emcure Pharms Ltd, Fresenius Kabi Usa, Hospira, Igi Labs Inc, Intl Medication, Luitpold, Marsam Pharms Llc, Smith And Nephew, Warner Chilcott, Watson Labs, West-ward Pharms Int, Wockhardt, Wyeth Ayerst, Wockhardt Bio Ag, Dava Pharms Inc, Ipca Labs Ltd, Ivax Sub Teva Pharms, Kalapharm, Leading Pharma Llc, Mylan, Prinston Inc, Sandoz, Sun Pharm Inds Inc, Sun Pharm Industries, Superpharm, and Watson Labs Teva. and is included in fifty-seven NDAs.
The generic ingredient in FUROSEMIDE is furosemide. There are twenty-one drug master file entries for this compound. Sixty-three suppliers are listed for this compound. Additional details are available on the furosemide profile page.
Summary for FUROSEMIDE
| US Patents: | 0 |
| Applicants: | 31 |
| NDAs: | 57 |
| Suppliers / Packagers: | 61 |
| Bulk Api Vendors: | 110 |
| Clinical Trials: | 163 |
| Patent Applications: | 4,063 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for FUROSEMIDE |
| DailyMed Link: | FUROSEMIDE at DailyMed |
Pharmacology for FUROSEMIDE
| Drug Class | Loop Diuretic |
| Physiological Effect | Increased Diuresis at Loop of Henle |
Medical Subject Heading (MeSH) Categories for FUROSEMIDE
Synonyms for FUROSEMIDE
| 106391-48-4 |
| 1z9y |
| 2-Furfurylamino-4-chloro-5-sulfamoylbenzoic acid |
| 4-chloranyl-2-(furan-2-ylmethylamino)-5-sulfamoyl-benzoic acid |
| 4-Chloro-2-((furan-2-ylmethyl)amino)-5-sulfamoylbenzoic acid |
| 4-chloro-2-(2-furanylmethylamino)-5-sulfamoylbenzoic acid |
| 4-chloro-2-(2-furylmethylamino)-5-sulfamoyl-benzoic acid |
| 4-chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoic acid |
| 4-chloro-2-[(2-furylmethyl)amino]-5-sulfamoylbenzoic acid |
| 4-chloro-2-[(furan-2-ylmethyl)amino]-5-sulfamoylbenzoic acid |
| 4-chloro-2-{[(furan-2-yl)methyl]amino}-5-sulfamoylbenzoic acid |
| 4-Chloro-5-sulfamoyl-N-furfuryl-anthranilic acid |
| 4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid |
| 4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid |
| 4-CHLORO-N-FURFURYL-5-SULFAMOYLANTHRANILIC ACID pound>>Fu |
| 4-CHLORO-N-FURFURYL-5-SULFAMOYLANTHRANILIC ACID pound>>Furosemide |
| 41733-55-5 (mono-hydrochloride salt) |
| 5-(Aminosulfamyl)-4-chloro-2-[(2-furanylmethyl)amino]benzoic acid |
| 5-(Aminosulfonyl)-4-chloro-2-((2-furanylmethyl)amino)benzoic acid |
| 5-(Aminosulfonyl)-4-chloro-2-([2-furanylmethyl]amino)benzoic acid |
| 5-(Aminosulfonyl)-4-chloro-2-[(2-furanylmethyl)amino]benzoic acid |
| 5-(Aminosulfonyl)-4-chloro-2-[(2-furylmethyl)amino]benzoic acid |
| 5-(Aminosulfonyl)-4-chloro-2-[(2-furylmethyl)amino]benzoic acid # |
| 5-(aminosulfonyl)-4-chloro-2-[(furan-2-ylmethyl)amino]benzoic acid |
| 5-[Aminosulfonyl]-4-chloro-2-[(2-furanylmethyl)-amino]benzoic acid |
| 5-18-09-00555 (Beilstein Handbook Reference) |
| 54-31-9 |
| 54F319 |
| 7LXU5N7ZO5 |
| A830094 |
| AB00052001 |
| AB00052001_12 |
| AB00052001_13 |
| AB00052001-10 |
| AB00052001-11 |
| AB0007947 |
| AB2000153 |
| ABP000639 |
| AC-11067 |
| AC1L1FXW |
| AC1Q557O |
| ACMC-20e7w6 |
| Aisemide |
| Aisemide (TN) |
| AK164514 |
| AKOS000266625 |
| ALBB-019200 |
| Aldalix |
| Aldic |
| Aluzine |
| AN-16917 |
| Anfuramaide |
| Anthranilic acid, 4-chloro-N-furfuryl-5-sulfamoyl- |
| API0002772 |
| Apo-Frusemide |
| Apo-Furosemide |
| Apo-Furosemide (TN) |
| Aquarid |
| Aquasin |
| Arasemide |
| ARONIS24304 |
| BBC/460 |
| BBL027780 |
| BC201654 |
| BCP9000708 |
| BDBM25902 |
| Benzoic acid, 5-(aminosulfonyl)-4-chloro-2-((2-furanylmethyl)amino)- |
| Benzoic acid, 5-(aminosulfonyl)-4-chloro-2-[(2-furanylmethyl)amino]- |
| Beronald |
| Beronald (TN) |
| BG0201 |
| BIDD:GT0139 |
| Bio-0044 |
| Bioretic |
| BP-13261 |
| BPBio1_000443 |
| BRD-K78010432-001-05-8 |
| BRN 0840915 |
| BSPBio_000401 |
| BSPBio_002054 |
| C-20036 |
| C07017 |
| C12H11ClN2O5S |
| CAS-54-31-9 |
| CC-28906 |
| CCG-40223 |
| CCRIS 1951 |
| Cetasix |
| CHEBI:47426 |
| CHEMBL35 |
| Chlor-N-(2-furylmethyl)-5-sulfamylanthranilsaeure |
| Chlor-N-(2-furylmethyl)-5-sulfamylanthranilsaeure [German] |
| CPD000058202 |
| CS-1915 |
| CTK0I1617 |
| D00331 |
| D0PQ3G |
| DB00695 |
| Depix |
| Desal |
| Desdemin |
| Desdemin (TN) |
| Dirine |
| Disal |
| Discoid |
| Discoid (TN) |
| Disemide |
| Diumide-K |
| Diural |
| Diural (TN) |
| Diurapid |
| Diurapid (TN) |
| Diurin |
| Diurolasa |
| Diusemide |
| Diusil |
| Diuzol |
| DivK1c_000575 |
| Dranex |
| Dryptal |
| Dryptal (TN) |
| DSSTox_CID_648 |
| DSSTox_GSID_20648 |
| DSSTox_RID_75710 |
| DTXSID6020648 |
| Durafurid |
| Durafurid (TN) |
| Edemid |
| Edenol |
| EINECS 200-203-6 |
| Eliur |
| Endural |
| Errolon |
| Errolon (TN) |
| Eutensin |
| Eutensin (TN) |
| F0182 |
| F4381_SIGMA |
| Farsix |
| Fluidrol |
| Fluss |
| Franyl |
| Frudix (TN) |
| Frumex |
| Frumide |
| Frumil (Salt/Mix) |
| Frusedan |
| Frusema |
| Frusemid |
| Frusemide |
| Frusemin |
| Frusenex |
| Frusetic |
| Frusetic (TN) |
| Frusid |
| Frusid (TN) |
| FT-0603229 |
| Fu sid |
| Fulsix |
| Fulsix (TN) |
| Fuluvamide |
| Fuluvamide (TN) |
| Fuluvamine |
| fulvamide |
| FUN |
| Furanthril |
| Furanthryl |
| Furantral |
| Furantril |
| Furanturil |
| Furesis |
| Furesis (TN) |
| Furetic |
| Furex |
| Furfan |
| Furix |
| Furix (TN) |
| Furmid |
| Furo-Basan |
| Furo-puren |
| Furo-Puren (TN) |
| Furobeta |
| Furocot |
| Furodiurol |
| Furodrix |
| Furomen |
| Furomex |
| Furomide M.D |
| Furomide M.D. |
| Furorese |
| Furosan |
| Furose |
| Furosedon |
| Furosedon (TN) |
| Furosemid |
| Furosemida |
| Furosemida [INN-Spanish] |
| furosemide ''mita'' |
| Furosemide "mita" |
| Furosemide (JP15/USP/INN) |
| Furosemide (JP17/USP/INN) |
| furosemide (lasix) |
| Furosemide (mita) |
| Furosemide [USAN:INN:JAN] |
| Furosemide [USAN:USP:INN:BAN:JAN] |
| Furosemide 1.0 mg/ml in Methanol |
| Furosemide for peak identification, European Pharmacopoeia (EP) Reference Standard |
| Furosemide Monohydrochloride |
| Furosemide Monosodium Salt |
| Furosemide oral |
| FUROSEMIDE USP |
| Furosemide, 4 |
| Furosemide, British Pharmacopoeia (BP) Reference Standard |
| Furosemide, European Pharmacopoeia (EP) Reference Standard |
| Furosemide, pharmaceutical secondary standard; traceable to USP, PhEur and BP |
| Furosemide, United States Pharmacopeia (USP) Reference Standard |
| furosemide(lasix) |
| Furosemide(Lasix)/ |
| Furosemidu |
| Furosemidu [Polish] |
| Furosemidum |
| Furosemidum [INN-Latin] |
| Furosemix |
| Furoside |
| Furosifar |
| Furosix |
| Furoter |
| Furovite |
| Fursemid |
| Fursemida |
| Fursemide |
| Fursol |
| Fusid |
| Golan |
| GTPL4839 |
| H788 |
| HE062527 |
| HE254977 |
| HE254978 |
| Hissuflux |
| HMS1569E03 |
| HMS1920B03 |
| HMS2090K06 |
| HMS2091H05 |
| HMS2096E03 |
| HMS2233H03 |
| HMS3259M03 |
| HMS3370J22 |
| HMS3655E09 |
| HMS501M17 |
| Hoe-058A |
| HSDB 3086 |
| HY-B0135 |
| Hydrex |
| Hydro |
| Hydro-rapid |
| Hydro-rapid(TN) |
| Hydroled |
| I04-0179 |
| IDI1_000575 |
| Impugan |
| Impugan (TN) |
| J10011 |
| Jenafusid |
| K-9798 |
| Katlex |
| Katlex (TN) |
| KBio1_000575 |
| KBio2_001580 |
| KBio2_004148 |
| KBio2_006716 |
| KBio3_001274 |
| KBioGR_001259 |
| KBioSS_001580 |
| Kofuzon |
| Kolkin |
| KS-1226 |
| KSC181M1P |
| Kutrix |
| Lasemid |
| Lasex |
| Lasiletten |
| Lasilix |
| Lasilix (TN) |
| Lasix |
| Lasix (TN) |
| Lasix Retard |
| Lasix Special |
| Lasix, Frusemide, Furosemide |
| Lasix;Frusemide |
| Laxur |
| Lazix |
| LB 502 |
| LB-502 |
| less Diur |
| Liside |
| Lodix (TN) |
| Logirene |
| Lowpston |
| Lowpston (TN) |
| Lowpstron |
| Luscek |
| Macasirool |
| Macasirool (TN) |
| Marsemide |
| MCULE-8037874224 |
| MFCD00010549 |
| Mirfat |
| Mirfat (TN) |
| Mita |
| MLS001066374 |
| MLS001306403 |
| MLS002548896 |
| Moilarorin |
| MolPort-001-641-065 |
| Myrosemide |
| Nadis |
| NC00453 |
| NCGC00016241-01 |
| NCGC00016241-02 |
| NCGC00016241-03 |
| NCGC00016241-04 |
| NCGC00016241-05 |
| NCGC00016241-06 |
| NCGC00016241-07 |
| NCGC00016241-08 |
| NCGC00016241-10 |
| NCGC00016241-11 |
| NCGC00090893-01 |
| NCGC00090893-02 |
| NCGC00090893-03 |
| NCGC00090893-05 |
| NCGC00090893-06 |
| NCGC00256523-01 |
| NCGC00259762-01 |
| NCI-C55936 |
| Nelsix |
| Neo-renal |
| Neosemid |
| Nephron |
| Nicorol (TN) |
| NINDS_000575 |
| Novosemide |
| NSC 269420 |
| NSC-269420 |
| NSC-757039 |
| NSC269420 |
| NSC757039 |
| Octan draselny |
| Odemase |
| Odemase (TN) |
| Odemex |
| Oedemex |
| Oedemex (TN) |
| Oprea1_667724 |
| OR5475 |
| Pharmakon1600-01500310 |
| Polysquall A |
| Prefemin |
| Prestwick_752 |
| Prestwick0_000341 |
| Prestwick1_000341 |
| Prestwick2_000341 |
| Prestwick3_000341 |
| Profemin |
| Profemin (TN) |
| Promedes |
| Promide |
| Protargen |
| PubChem7165 |
| Puresis |
| Radisemide |
| Radonna |
| Radouna |
| Retep |
| Rosemide |
| Rosemide (TN) |
| Rosis |
| RT-000186 |
| Rusyde |
| Rusyde (TN) |
| Sal diureticum |
| Salinex |
| Salix |
| Salix (brand of furosemide) |
| Salix (TN) |
| Salurex |
| Salurid |
| SAM002264614 |
| SBB012613 |
| SBI-0051389.P003 |
| SC-05214 |
| SCHEMBL9811 |
| Seguril |
| Selectofur |
| Sigasalur |
| SMP1_000129 |
| SMR000058202 |
| SPBio_001129 |
| SPBio_002322 |
| Spectrum_001100 |
| SPECTRUM1500310 |
| Spectrum2_001005 |
| Spectrum3_000437 |
| Spectrum4_000560 |
| Spectrum5_000744 |
| Spirofur |
| SR-01000765380 |
| SR-01000765380-7 |
| ST005581 |
| STK177334 |
| Synephron |
| TL8003563 |
| Tox21_110322 |
| Tox21_110322_1 |
| Tox21_202213 |
| Tox21_302971 |
| Transit |
| Trofurit |
| Trofurit (TN) |
| UNII-7LXU5N7ZO5 |
| UPCMLD-DP022 |
| UPCMLD-DP022:001 |
| Uremide |
| Uresix |
| Urex |
| Urex M |
| Urex-M |
| Urian |
| Uridon |
| Uritol |
| Urosemide |
| Vesix |
| WLN: T5OJ B1MR CG FVQ DSZW |
| Yidoli |
| Z275128584 |
| Zafimida |
| Zafurida |
| ZINC35804 |
| ZX-AN034923 |
| ZX-AS004664 |
| ZX-AT016383 |
| ZZUFCTLCJUWOSV-UHFFFAOYSA-N |
US Patents and Regulatory Information for FUROSEMIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | FUROSEMIDE | furosemide | TABLET;ORAL | 018369-002 | May 14, 1982 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Kalapharm | FUROSEMIDE | furosemide | TABLET;ORAL | 018868-001 | Jun 28, 1983 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Dava Pharms Inc | FUROSEMIDE | furosemide | TABLET;ORAL | 018415-002 | Jul 27, 1982 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Prinston Inc | FUROSEMIDE | furosemide | TABLET;ORAL | 076796-001 | Mar 26, 2004 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Sun Pharm Industries | FUROSEMIDE | furosemide | TABLET;ORAL | 070043-001 | Sep 26, 1985 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Leading Pharma Llc | FUROSEMIDE | furosemide | TABLET;ORAL | 077293-003 | Nov 9, 2005 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
see a sample report or, see our see our flat-rate plans
